{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:13:38Z","timestamp":1774570418508,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaip.2017.04.033","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T12:16:06Z","timestamp":1495714566000},"page":"1207-1211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Are ACE Inhibitors and Beta-blockers Dangerous in Patients at Risk for Anaphylaxis?"],"prefix":"10.1016","volume":"5","author":[{"given":"Christopher A.","family":"Coop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca S.","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore M.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.04.033_bib1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Health Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib2","series-title":"Middleton's Allergy: Principles and Practice","first-page":"1237","article-title":"Anaphylaxis","author":"Brown","year":"2014"},{"key":"10.1016\/j.jaip.2017.04.033_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18176\/jiaci.0046","article-title":"Mechanisms of anaphylaxis beyond IgE","volume":"26","author":"Munoz-Cano","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib4","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1081-1206(10)61086-1","article-title":"Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group","volume":"97","author":"Lieberman","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamaoto.2015.8","article-title":"A\u00a0patient with an allergy emergency","volume":"141","author":"Houser","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2017.04.033_bib6","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199106203242506","article-title":"Anaphylaxis","volume":"324","author":"Bochner","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.04.033_bib7","first-page":"929","article-title":"Beta-blocker therapy and the risk of anaphylaxis","volume":"136","author":"Toogood","year":"1987","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jaip.2017.04.033_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1081-1206(10)60545-5","article-title":"Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue","volume":"99","author":"Evora","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib10","doi-asserted-by":"crossref","first-page":"264.e3","DOI":"10.1016\/j.ajem.2012.03.036","article-title":"Methylene blue for the treatment of refractory anaphylaxis without hypotension","volume":"31","author":"Bauer","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jaip.2017.04.033_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/0003-4819-105-1-65","article-title":"Glucagon reversal of hypotension in a case of anaphylactoid shock","volume":"105","author":"Zaloga","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2017.04.033_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/ACI.0000000000000080","article-title":"Pharmacotherapy in refractory anaphylaxis: when intramuscular epinephrine fails","volume":"14","author":"Kemp","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib13","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.04.033_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0091-6749(81)90170-6","article-title":"Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade","volume":"68","author":"Jacobs","year":"1981","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib15","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJM198306233082513","article-title":"Severe anaphylaxis and drug-induced beta-blockade","volume":"308","author":"Hannaway","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.04.033_bib16","first-page":"97","article-title":"Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient","volume":"32","author":"Odeh","year":"1991","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.jaip.2017.04.033_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212432","article-title":"Use of enoximone in management of anaphylaxis complicated by labetalol use","author":"Hayhoe","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaip.2017.04.033_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","article-title":"Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis","volume":"131","author":"Lee","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1398-9995.1998.tb03855.x","article-title":"Anaphylaxis to walnuts and pine nuts induced by ACE","volume":"53","author":"Moneret-Vautrin","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.04.033_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/jch.12515","article-title":"Severe angioedema associated with angiotensin-converting enzyme inhibitor therapy in two patients with pollen-food allergy syndrome","volume":"17","author":"Ferastraoaru","year":"2015","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jaip.2017.04.033_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaci.2007.12.003","article-title":"Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center","volume":"121","author":"Summers","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib22","first-page":"977","article-title":"Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis","volume":"113","author":"TenBrook","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0889-8561(22)00134-5","article-title":"Anaphylactic reactions to radiocontrast material","volume":"12","author":"Lieberman","year":"1992","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.04.033_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-115-4-270","article-title":"Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma","volume":"115","author":"Lang","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2017.04.033_bib25","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/archinte.1993.00410170119012","article-title":"Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders","volume":"153","author":"Lang","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2017.04.033_bib26","first-page":"383","article-title":"Refractory anaphylactoid shock potentiated by beta-blockers","volume":"39","author":"Javeed","year":"1996","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1016\/j.jaip.2017.04.033_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcct.2015.02.003","article-title":"\u03b2-Blocker premedication does not increase the frequency of allergic reactions from coronary CT angiography: results from the Advanced Cardiovascular Imaging Consortium","volume":"9","author":"Aggarwal","year":"2015","journal-title":"J\u00a0Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jaip.2017.04.033_bib28","first-page":"48","article-title":"Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication","volume":"53","author":"Awai","year":"1984","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2017.04.033_bib29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0091-6749(90)90111-G","article-title":"Relapsing anaphylaxis to bee sting in a patient treated with beta-blocker and Ca blocker","volume":"85","author":"Kivity","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase\u2014a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Ru\u00ebff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib31","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2014a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1710-1492-6-2","article-title":"Skin prick testing in patients using beta-blockers: a retrospective analysis","volume":"6","author":"Fung","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib34","first-page":"35","article-title":"Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride","volume":"47","author":"Newman","year":"1981","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jaip.2017.04.033_bib35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0091-6749(87)80164-1","article-title":"Fatalities from immunotherapy (IT) and skin testing (ST)","volume":"79","author":"Lockey","year":"1987","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2017.04.033_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(93)90030-J","article-title":"Survey of fatalities from skin testing and immunotherapy 1985-1989","volume":"92","author":"Reid","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2017.04.033_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1081-1206(10)62195-3","article-title":"Systemic reactions and fatalities associated with allergen immunotherapy","volume":"87","author":"Lockey","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2005.10.010","article-title":"Evaluation of near-fatal reactions to allergen immunotherapy injections","volume":"117","author":"Amin","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.anai.2016.02.014","article-title":"Safety and tolerability during build-up phase of a rush venom immunotherapy","volume":"116","author":"Bernkopf","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0140-6736(92)93314-D","article-title":"ACE inhibitors and anaphylactoid reactions during venom immunotherapy","volume":"340","author":"Tunon-de-Lara","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2017.04.033_bib42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0091-6749(03)01940-7","article-title":"Life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor","volume":"112","author":"Ober","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Pt 1","key":"10.1016\/j.jaip.2017.04.033_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-6749(05)80105-8","article-title":"Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections","volume":"86","author":"Hepner","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1081-1206(10)60321-3","article-title":"Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy","volume":"101","author":"White","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2500\/aap.2008.29.3141","article-title":"Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors","volume":"29","author":"Rank","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2017.04.033_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase","volume":"126","author":"Ru\u00ebff","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.04.033_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.anai.2015.03.001","article-title":"Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective","volume":"114","author":"Stoevesandt","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2004.11.012","article-title":"Use of beta-blockers during immunotherapy for\u00a0Hymenoptera venom allergy","volume":"115","author":"M\u00fcller","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.033_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.anai.2016.10.031","article-title":"Stinging insect hypersensitivity: a practice parameter update 2016","volume":"118","author":"Golden","year":"2017","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817303495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817303495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:12:54Z","timestamp":1761973974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817303495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213219817303495"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.033","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are ACE Inhibitors and Beta-blockers Dangerous in Patients at Risk for Anaphylaxis?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}